118 related articles for article (PubMed ID: 1456445)
1. Radioiodination of the active site of tissue plasminogen activator: a method for radiolabeling serine proteases with tyrosylprolylarginyl chloromethyl ketone.
Keyt BA; Berleau LT; Nguyen HV; Bennett WF
Anal Biochem; 1992 Oct; 206(1):73-83. PubMed ID: 1456445
[TBL] [Abstract][Full Text] [Related]
2. Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.
Bock PE
Biochemistry; 1988 Aug; 27(17):6633-9. PubMed ID: 3219359
[TBL] [Abstract][Full Text] [Related]
3. Lysine 156 promotes the anomalous proenzyme activity of tPA: X-ray crystal structure of single-chain human tPA.
Renatus M; Engh RA; Stubbs MT; Huber R; Fischer S; Kohnert U; Bode W
EMBO J; 1997 Aug; 16(16):4797-805. PubMed ID: 9305622
[TBL] [Abstract][Full Text] [Related]
4. Visualization of thrombi in pulmonary arteries with radiolabeled, enzymatically inactivated tissue-type plasminogen activator.
De Bruyn VH; Bergmann SR; Keyt BA; Sobel BE
Circulation; 1995 Sep; 92(5):1320-5. PubMed ID: 7648681
[TBL] [Abstract][Full Text] [Related]
5. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
6. Tissue plasminogen activator binds to human vascular smooth muscle cells by a novel mechanism. Evidence for a reciprocal linkage between inhibition of catalytic activity and cellular binding.
Werner F; Razzaq TM; Ellis V
J Biol Chem; 1999 Jul; 274(31):21555-61. PubMed ID: 10419460
[TBL] [Abstract][Full Text] [Related]
7. Scintigraphic visualization of pulmonary thrombi with 123I-YPACK-TNK-tPA.
De Bruyn VH; Bergmann R; Keyt BA; Bennett WF; Sobel BE
Coron Artery Dis; 1995 Sep; 6(9):715-21. PubMed ID: 8747877
[TBL] [Abstract][Full Text] [Related]
8. Distal hinge of plasminogen activator inhibitor-1 involves its latency transition and specificities toward serine proteases.
Wang Q; Shaltiel S
BMC Biochem; 2003 Jul; 4():5. PubMed ID: 12848892
[TBL] [Abstract][Full Text] [Related]
9. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of the plasminogen activator from HeLa cells by peptides of arginine chloromethyl ketone.
Coleman P; Kettner C; Shaw E
Biochim Biophys Acta; 1979 Jul; 569(1):41-51. PubMed ID: 111716
[TBL] [Abstract][Full Text] [Related]
11. Iodination of peptidyl chloromethyl ketones for protease affinity labels.
Rauber P; Wikstrom P; Shaw E
Anal Biochem; 1988 Feb; 168(2):259-64. PubMed ID: 3163239
[TBL] [Abstract][Full Text] [Related]
12. The inactivation of one- and two-chain forms of tissue plasminogen activator by a series of peptidyl chloromethyl ketones.
Green GD
Thromb Res; 1986 Oct; 44(2):175-83. PubMed ID: 3097870
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator domain-deletion mutant BM 06.022: modular stability, inhibitor binding, and activation cleavage.
Hu CK; Kohnert U; Wilhelm O; Fischer S; Llinás M
Biochemistry; 1994 Oct; 33(39):11760-6. PubMed ID: 7918392
[TBL] [Abstract][Full Text] [Related]
14. Molecular basis of specific inhibition of urokinase plasminogen activator by amiloride.
Jankun J; Skrzypczak-Jankun E
Cancer Biochem Biophys; 1999 Jul; 17(1-2):109-23. PubMed ID: 10738907
[TBL] [Abstract][Full Text] [Related]
15. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
Talbot K; Meixner SC; Pryzdial EL
Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
[TBL] [Abstract][Full Text] [Related]
16. Active-site-selective labeling of blood coagulation proteinases with fluorescence probes by the use of thioester peptide chloromethyl ketones. I. Specificity of thrombin labeling.
Bock PE
J Biol Chem; 1992 Jul; 267(21):14963-73. PubMed ID: 1634535
[TBL] [Abstract][Full Text] [Related]
17. Absence of specific cell-surface binding of tissue plasminogen activator in uterine cells.
Ayub M; Jenkins N; White JO
J Mol Endocrinol; 1990 Aug; 5(1):7-14. PubMed ID: 2168711
[TBL] [Abstract][Full Text] [Related]
18. The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Biochim Biophys Acta; 1979 Jul; 569(1):31-40. PubMed ID: 465506
[TBL] [Abstract][Full Text] [Related]
19. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
Rydzewski A; Castellino FJ
Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator mutants imitating urokinase in the peptide link between kringle and protease domains and at selected sites within the protease domain.
Hinzmann B; Wernicke D; Pfeifer M; Zacharias U; Fischer B; Eisenmenger F; Will H
Eur J Biochem; 1993 Apr; 213(1):437-43. PubMed ID: 8386628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
